Goldman Sachs’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-323,900
Closed -$1.4M 6544
2025
Q2
$1.4M Sell
323,900
-355,800
-52% -$1.76M ﹤0.01% 4455
2025
Q1
$4.1M Sell
679,700
-2,589,600
-79% -$13.1M ﹤0.01% 3554
2024
Q4
$12.9M Sell
3,269,300
-1,341,800
-29% -$6.01M ﹤0.01% 2556
2024
Q3
$27M Buy
4,611,100
+1,755,000
+61% +$8.65M ﹤0.01% 1786
2024
Q2
$12.3M Buy
2,856,100
+2,056,100
+257% +$9.85M ﹤0.01% 2306
2024
Q1
$3.76M Buy
+800,000
New +$3.06M ﹤0.01% 3359
2023
Q2
Sell
-257,800
Closed -$2.12M 5949
2023
Q1
$2.12M Buy
257,800
+224,200
+667% +$2.48M ﹤0.01% 3816
2022
Q4
$374K Sell
33,600
-66,400
-66% -$772K ﹤0.01% 5025
2022
Q3
$1.19M Buy
+100,000
New +$1.51M ﹤0.01% 4392

Other funds holding MPT

Goldman Sachs's MPT Position: Q2 2026 in Review

Goldman Sachs increased its Medical Properties Trust (MPT) stake by 68% in Q2 2026, buying an estimated $6.38M and bringing the position to 3,195,565 shares worth $14.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2924.

Goldman Sachs first reported a position in MPT in Q2 2013 and has held it in 53 quarters since. The position peaked at $85.6M in Q3 2022. 489 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Goldman Sachs held 3,195,565 shares of Medical Properties Trust worth $14.8M as of Q2 2026.
  • Goldman Sachs bought 1,288,007 Medical Properties Trust shares in Q2 2026, an estimated $6.38M.
  • Medical Properties Trust made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2924 holding.
  • Goldman Sachs first reported a position in Medical Properties Trust in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Medical Properties Trust position peaked at $85.6M in Q3 2022.
  • 489 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.